Healthcare Investment Innovation – Waud Capital’s Strategic Promotions Signal Industry Focus
Waud Capital Partners’ recent announcement of partner promotions highlights the firm’s deepening commitment to healthcare investment expertise. With the elevation of Tim Cremieux and Kyle Lattner within the Healthcare Group, the Chicago-based private equity firm reinforces its strategic focus on this vital sector.
These promotions build upon the foundation Reeve Waud established when founding the firm in 1993. By cultivating specialized talent across healthcare subsectors, Waud Capital has positioned itself to identify promising opportunities and create significant value for investors and portfolio companies alike.
Specialized Expertise Across Healthcare Sectors
The newly promoted partners bring complementary skills that strengthen Waud Capital’s healthcare investment capabilities. Tim Cremieux, who joined in 2017, focuses on pharma services, payor services, medication supply chain, and wellness & functional medicine. His work on the PharmAlliance platform investment demonstrates his ability to identify promising companies in these spaces.
Kyle Lattner, with the firm since 2013, brings expertise in medical device and supply chain services, home care, multi-site providers, and behavioral health. His involvement with Senior Helpers and Mopec Group investments, along with his ongoing support for APDerm and Ivy Rehab, showcases the breadth of his healthcare knowledge.
Building on a Legacy of Healthcare Success
This focus on healthcare sector specialization reflects Reeve B. Waud‘s long-standing commitment to the industry. One of the firm’s notable healthcare successes was Acadia Healthcare, which grew into a leading behavioral health provider under Waud Capital’s guidance.
The promotion of Mike Lehman to Principal further strengthens the Healthcare Group. Having joined in 2021, Lehman supports Ivy Rehab, Unifeye Vision Partners, and the firm’s newest healthcare investment, Mopec Group, indicating Waud Capital’s ongoing commitment to building depth across healthcare subsectors.
A Thesis-Driven Approach to Healthcare Investing
Waud Capital’s healthcare investment strategy combines deep sector expertise with a systematic approach to identifying opportunities. This methodology allows the firm to spot emerging trends and position its portfolio companies for success in an increasingly complex healthcare environment.
As Chris Graber, Partner and Head of the Healthcare Group, noted in the announcement, the newly promoted partners “have demonstrated extraordinary leadership, delivering value, insights and expertise to their portfolio companies and contributing to the continued success of Waud Capital.”
Positioned for Future Healthcare Opportunities
The strategic promotions come at a time when healthcare continues to present compelling investment opportunities. Reeve Waud’s early recognition of healthcare’s potential has evolved into a sophisticated investment practice that spans multiple subsectors.
With strengthened leadership, Waud Capital is well-positioned to identify promising companies, implement value-creation strategies, and navigate regulatory complexities. The firm’s talent-led approach ensures that it maintains the specialized knowledge necessary to succeed in healthcare investing.
As the firm enters 2025, these promotions signal Waud Capital’s continued commitment to healthcare as a core investment focus, building on three decades of experience while adapting to emerging opportunities across the sector.
